US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Genaissance Pharmaceuticals (MM) (GNSC)
Genaissance Pharmaceuticals (MM) (GNSC) ニュース

GNSC

Genaissance (GNSC)

Genaissance Pharmaceuticals (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GNSC

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2005/10/03	21 : 00	PR Newswire (US)	Genaissance Enters into HAP(TM) Technology License Agreement with Sankyo	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/09/21	21 : 00	PR Newswire (US)	Genaissance Enters Pharmacogenomic Collaboration with Otsuka	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/09/12	21 : 00	PR Newswire (US)	Genaissance Pharmaceuticals and Ipsogen Announce Cancer Biomarker Research Agreements	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/08/23	21 : 30	PR Newswire (US)	Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/08/11	21 : 30	PR Newswire (US)	Genaissance Will Provide Exclusive Genotyping Services for Greek Scrapie Contract	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/07/18	21 : 30	PR Newswire (US)	Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/06/21	21 : 15	PR Newswire (US)	Clinical Data to Acquire Genaissance Pharmaceuticals	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/06/21	20 : 15	Business Wire	Clinical Data to Acquire Genaissance Pharmaceuticals; Combined Company to Deliver Industry-Defining Theranostics	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/06/07	21 : 30	PR Newswire (US)	Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/05/03	21 : 30	PR Newswire (US)	Genaissance Reports First Quarter 2005 Results	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/04/29	05 : 23	PR Newswire (US)	Genaissance Pharmaceuticals Comments on Stock Activity	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/04/28	00 : 00	PR Newswire (US)	Genaissance Pharmaceuticals to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/04/27	00 : 00	PR Newswire (US)	Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2005 Conference Call	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/04/22	21 : 31	PR Newswire (US)	Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/04/22	21 : 30	PR Newswire (US)	Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/04/06	21 : 32	PR Newswire (US)	Genaissance and ParAllele BioScience Sign License and Co-Marketing Agreement	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/04/01	01 : 30	PR Newswire (US)	Genaissance Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/03/23	02 : 00	PR Newswire (US)	Genaissance Comments on FDA Guidance on Pharmacogenomics	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/03/11	21 : 30	PR Newswire (US)	Genaissance Allowed Patent for Method of Testing Individuals for Genetic Predisposition to Reduced Metabolism of Drugs	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/03/09	22 : 00	PR Newswire (US)	Genaissance and Monsanto Company Team Up with the USDA to Map Soybean Genome	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/03/09	22 : 00	PR Newswire (US)	Genaissance and Monsanto Company Team Up With the USDA to Map Soybean Genome	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/02/15	21 : 30	PR Newswire (US)	Genaissance Pharmaceuticals' New DNA Test - FAMILION(TM) - Becoming Key Tool for Detecting Long QT Syndrome, a Potentially Fatal	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/02/10	23 : 00	PR Newswire (US)	Genaissance Pharmaceuticals Reports 2004 Results	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/02/04	00 : 00	PR Newswire (US)	Genaissance Pharmaceuticals, Inc. Invites You to Participate in its Fourth Quarter 2004 Conference Call	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/01/26	21 : 30	PR Newswire (US)	Genaissance Obtains License to Vanderbilt Patent Linking Genetics to Key Drug Safety Issue	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/01/24	21 : 30	PR Newswire (US)	Genaissance Study Sheds Light on Mechanism of Heart Disease Risk by Linking Genetic Variation to the Effect of Hormone Replaceme	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2005/01/04	21 : 30	PR Newswire (US)	Genaissance Allowed Patent for Novel Methods to Correlate Genetics With Drug Safety and Efficacy	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2004/12/20	21 : 30	PR Newswire (US)	Genaissance Identifies Genetic Markers Implicated in Fatal Side Effects Of Schizophrenia Drug	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2004/12/02	21 : 00	PR Newswire (US)	Genaissance Pharmaceuticals Signs Research Agreement With Sygen International	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
2004/11/19	22 : 56	PR Newswire (US)	Genaissance to Raise Approximately $6 Million in Private Placement	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)

Showing the most relevant articles for your search:NASDAQ:GNSC

1 2 3 次へ >>

Ispire Technology

XMUEUE1DUSDINAV

Jpmorgan Chase Financial...

Societe Generale Effekten

S&p Midcap 400 Dividend ...

Intact Financial

BRFSF275 Ex:27,5

Jpmorgan Chase Financial...

Lululemon Athletica

DeFiYieldProtocol

ChainLink Token

Vontobel Financial Produ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約